Brandywine Global Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $106M | Buy |
861,496
+158,393
| +23% | +$19.2M | 0.71% | 31 |
|
|
2025
Q3 | $78M | Buy |
703,103
+3,385
| +0.5% | +$385K | 0.54% | 41 |
|
|
2025
Q2 | $77.6M | Sell |
699,718
-5,650
| -0.8% | -$601K | 0.55% | 42 |
|
|
2025
Q1 | $79M | Sell |
705,368
-34,729
| -5% | -$3.58M | 0.57% | 41 |
|
|
2024
Q4 | $68.4M | Buy |
740,097
+568,319
| +331% | +$51.2M | 0.5% | 49 |
|
|
2024
Q3 | $14.6M | Buy |
+171,778
| New | +$13.1M | 0.1% | 200 |
|
|
2024
Q2 | – | Sell |
-638,993
| Closed | -$46.8M | – | 709 |
|
|
2024
Q1 | $46.8M | Sell |
638,993
-921,710
| -59% | -$70.9M | 0.34% | 81 |
|
|
2023
Q4 | $126M | Buy |
1,560,703
+25,687
| +2% | +$2M | 1.02% | 14 |
|
|
2023
Q3 | $115M | Buy |
1,535,016
+388,482
| +34% | +$29.9M | 1.01% | 14 |
|
|
2023
Q2 | $88.4M | Buy |
1,146,534
+357,482
| +45% | +$28.5M | 0.74% | 30 |
|
|
2023
Q1 | $65.5M | Buy |
789,052
+31,648
| +4% | +$2.62M | 0.53% | 50 |
|
|
2022
Q4 | $65M | Sell |
757,404
-52,590
| -6% | -$4.16M | 0.51% | 51 |
|
|
2022
Q3 | $50M | Sell |
809,994
-13,965
| -2% | -$881K | 0.47% | 62 |
|
|
2022
Q2 | $50.9M | Sell |
823,959
-49,301
| -6% | -$3.05M | 0.44% | 66 |
|
|
2022
Q1 | $51.9M | Sell |
873,260
-42,203
| -5% | -$2.7M | 0.38% | 76 |
|
|
2021
Q4 | $66.5M | Buy |
915,463
+40,625
| +5% | +$2.8M | 0.47% | 50 |
|
|
2021
Q3 | $61.1M | Buy |
+874,838
| New | +$61.5M | 0.46% | 57 |
|
|
2020
Q4 | – | Sell |
-1,061,493
| Closed | -$67.1M | – | 643 |
|
|
2020
Q3 | $67.1M | Sell |
1,061,493
-37,427
| -3% | -$2.6M | 0.66% | 31 |
|
|
2020
Q2 | $84.6M | Sell |
1,098,920
-226,543
| -17% | -$17.4M | 0.86% | 21 |
|
|
2020
Q1 | $99.1M | Sell |
1,325,463
-427,396
| -24% | -$29.5M | 1.18% | 16 |
|
|
2019
Q4 | $114M | Buy |
1,752,859
+58,355
| +3% | +$3.8M | 0.81% | 24 |
|
|
2019
Q3 | $107M | Sell |
1,694,504
-109,686
| -6% | -$7.17M | 0.79% | 27 |
|
|
2019
Q2 | $122M | Sell |
1,804,190
-29,655
| -2% | -$1.95M | 0.84% | 25 |
|
|
2019
Q1 | $119M | Buy |
1,833,845
+93,552
| +5% | +$6.22M | 0.82% | 27 |
|
|
2018
Q4 | $109M | Sell |
1,740,293
-134,860
| -7% | -$9.43M | 0.81% | 29 |
|
|
2018
Q3 | $145M | Sell |
1,875,153
-61,618
| -3% | -$4.65M | 0.9% | 22 |
|
|
2018
Q2 | $137M | Sell |
1,936,771
-30,548
| -2% | -$2.16M | 0.88% | 24 |
|
|
2018
Q1 | $148M | Buy |
1,967,319
+89,084
| +5% | +$7.08M | 0.93% | 21 |
|
|
2017
Q4 | $135M | Buy |
1,878,235
+662,386
| +54% | +$50.3M | 0.8% | 27 |
|
|
2017
Q3 | $98.5M | Buy |
1,215,849
+444,038
| +58% | +$34M | 0.62% | 41 |
|
|
2017
Q2 | $54.6M | Sell |
771,811
-344,382
| -31% | -$22.9M | 0.35% | 68 |
|
|
2017
Q1 | $75.8M | Sell |
1,116,193
-11,268
| -1% | -$792K | 0.48% | 55 |
|
|
2016
Q4 | $80.7M | Buy |
1,127,461
+68,851
| +7% | +$5.12M | 0.51% | 49 |
|
|
2016
Q3 | $83.8M | Sell |
1,058,610
-1,005,620
| -49% | -$81.7M | 0.55% | 49 |
|
|
2016
Q2 | $172M | Buy |
2,064,230
+724,824
| +54% | +$64.3M | 1.16% | 16 |
|
|
2016
Q1 | $123M | Sell |
1,339,406
-14,478
| -1% | -$1.31M | 0.8% | 31 |
|
|
2015
Q4 | $137M | Buy |
1,353,884
+60,711
| +5% | +$6.32M | 0.87% | 23 |
|
|
2015
Q3 | $127M | Buy |
1,293,173
+376,896
| +41% | +$41.9M | 0.83% | 24 |
|
|
2015
Q2 | $107M | Buy |
916,277
+75,610
| +9% | +$8.26M | 0.67% | 32 |
|
|
2015
Q1 | $82.5M | Buy |
840,667
+492,431
| +141% | +$50M | 0.53% | 42 |
|
|
2014
Q4 | $32.8M | Buy |
+348,236
| New | +$36M | 0.22% | 100 |
|
Other funds holding GILD
Brandywine Global Investment Management's GILD Position: Q4 2025 in Review
Brandywine Global Investment Management increased its Gilead Sciences (GILD) stake by 23% in Q4 2025, buying an estimated $19.2M and bringing the position to 861,496 shares worth $106M. The position accounts for 0.71% of the portfolio, ranked #31.
Brandywine Global Investment Management first reported a position in GILD in Q4 2014 and has held it in 41 quarters since. The position peaked at $172M in Q2 2016. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Brandywine Global Investment Management held 861,496 shares of Gilead Sciences worth $106M as of Q4 2025.
- Brandywine Global Investment Management bought 158,393 Gilead Sciences shares in Q4 2025, an estimated $19.2M.
- Gilead Sciences made up 0.71% of Brandywine Global Investment Management's portfolio in Q4 2025, its #31 holding.
- Brandywine Global Investment Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 41 quarters since.
- Brandywine Global Investment Management's Gilead Sciences position peaked at $172M in Q2 2016.
- 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.